Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bupropion in atopic dermatitis.

E González, R M Sanguino, M A Franco

    Pharmacopsychiatry
    |November 25, 2006
    PubMed
    Summary
    This summary is machine-generated.

    Bupropion, an antidepressant, showed significant improvement in severe atopic dermatitis (A.D.) in a case study. This suggests bupropion may be a novel therapeutic option for treatment-resistant A.D.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Comparative efficacy and side effects of the treatment of euthyroid goiter with levo-thyroxine or triiodothyroacetic acid.

    The Journal of clinical endocrinology and metabolism·2003
    Same author

    [Interaction of caffeine with basic nucleic acids my a molecular mechanic method].

    Biofizika·2003
    Same author

    [Possible configuration of dimers of Gua-Cyt bases. Computation by molecular mechanic models and density functional theory].

    Biofizika·2003
    Same author

    Methodologies for determining capture efficiencies in surface treatment tanks.

    AIHA journal : a journal for the science of occupational and environmental health and safety·2003
    Same author

    Results of kidney transplantation in recipients over 70 years of age: experience at a single center.

    Transplantation proceedings·2003
    Same author

    Helical computed tomography angiography is the most efficient test to assess vascular calcifications in the iliac arterial sector in renal transplant candidates.

    Transplantation proceedings·2003
    Same journal

    A Tribute to Prof. Jules Angst highlighting his Contributions to Clozapine.

    Pharmacopsychiatry·2026
    Same journal

    Correction: Escitalopram and Clonazepam Affect Gasotransmitter-related Enzyme (nNOS, HO-2, CBS) Gene Expression in the Rat Brain.

    Pharmacopsychiatry·2026
    Same journal

    Correction: Non-Response to Antidepressants: Risk Factors and Therapeutic Possibilities.

    Pharmacopsychiatry·2026
    Same journal

    Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2026 - Pharmacokinetic, pharmacogenetic and clinical aspects.

    Pharmacopsychiatry·2026
    Same journal

    Therapeutic Drug Monitoring of Cannabinoids: Therapeutic Reference Ranges for Delta-9-tetrahydrocannabinol in Medical Cannabis, Nabiximols, Dronabinol and Nabilone.

    Pharmacopsychiatry·2026
    Same journal

    A Naturalistic Study on the Cost Reduction and Efficacy of Long-acting Antipsychotics in an Early Intervention Programme for Patients with Recent-onset Psychosis.

    Pharmacopsychiatry·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Dermatology
    • Neuroscience

    Background:

    • Atopic dermatitis (A.D.) is a chronic inflammatory skin condition with complex, multifactorial pathophysiology.
    • Current treatments for severe A.D. often have limitations or are ineffective in some patients.
    • Bupropion is an antidepressant primarily acting as a norepinephrine and dopamine reuptake inhibitor.

    Observation:

    • A case study involved a 50-year-old individual with severe, treatment-resistant atopic dermatitis.
    • This patient had no concurrent psychiatric conditions.
    • The individual was incidentally treated with bupropion.

    Findings:

    • The patient experienced a remarkable positive response to bupropion treatment for their severe atopic dermatitis.
    • The exact mechanisms underlying bupropion's efficacy in A.D. are currently unknown.

    Related Experiment Videos

  • The observed results suggest a potential benefit of bupropion beyond its established antidepressant effects.

    • Implications:

    • Bupropion may represent a novel therapeutic avenue for severe and refractory atopic dermatitis.
    • Further research is warranted to elucidate the pharmacologic and molecular mechanisms of bupropion in A.D.
    • This case highlights the potential for repurposing existing medications in dermatology.